Vasil Haykin

Dr. Vasil Haykin

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2020 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
VHVasil Haykin
Vasil Haykin
AOAlexander Oscar
Alexander Oscar
VDVioleta S Dimitrova
Violeta S Dimitrova
IPIva Petkova
Iva Petkova
YZYani Zdravkov
Yani Zdravkov
AIAntonia Isaeva
Antonia Isaeva
Cataract is a multifactorial disease with increasing prevalence with age. Adult diabetics develop cataract earlier. Lens epithelial cells (LECs) exposed to oxidative stress (ROS), increased calcium deposit and membrane damage, undergo apoptosis, which results in lens opacification. Remaining LECs post-surgery leads to posterior capsular opacification (PCO). This study’s aim was to investigate the physiological characteristics of LECs from cataractous diabetic and non-diabetic lenses. Leader cells migration from age-related cataracts started on day 5–7 and from type-2 diabetics on day 8–10. Differences were found in the collective migratory activity and colony formation. On day 22, the colonies formed by LECs from age-related cataracts were three times more, than those formed by diabetic LECs. DNA synthesis and FOXM1 expression occurred in 55.76% of age-related cataract LECs, but only in 33.45% of diabetic LECs. The highest level of reactive oxygen species (ROS) was found in diabetic LECs. Extracellular matrix calcification followed the same pattern as ROS. Among the main reasons for the development of age-related and diabetic cataracts is lens damage due to ROS release and elevated calcium levels. Diabetic LECs experience significantly lower in vitro migration and proliferative activities, compared to LECs from age-related cataracts. This is the first study of its kind in Bulgaria, contributing to the elucidation of the mechanisms of primary and secondary cataractogenesis in diabetic and non-diabetic adults.

25 September 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
YZYani Zdravkov
Yani Zdravkov
RDRadomir Dzhambazov
Radomir Dzhambazov
NVNevyana Veleva-Krasteva
Nevyana Veleva-Krasteva
VHVasil Haykin
Vasil Haykin
AOAlexander Oscar
Alexander Oscar
This retrospective study aimed to evaluate the postoperative visual acuity and overall patient satisfaction of three groups of patients who underwent cataract surgery. A total of 56 patients and 67 eyes were evaluated and divided based on the type of intraocular lens (IOL) implanted. The evaluation consisted of examining visual acuity at far and intermediate distances preoperatively and postoperatively. On the 30 th postoperative day, contrast sensitivity was evaluated using the Pelli-Robson chart, and all patients completed a questionnaire addressing patient satisfaction at far and intermediate distances, dependence on spectacles, occurrence of halos and glare, and driving difficulties. The present study highlights a clinically relevant intermediate vision advantage of the Evolux™ enhanced monofocal IOL over a standard monofocal IOL while maintaining comparable distance visual acuity and contrast sensitivity. Although extended depth of focus (EDOF) IOLs provided superior intermediate visual acuity, they were associated with lower contrast sensitivity and more frequent photic phenomena in this cohort. The study highlights that enhanced monofocal IOLs may represent a useful compromise between the limited intermediate vision of conventional monofocal lenses and the optical trade-offs associated with EDOF lenses. Larger prospective studies with standardized patient-reported outcome measures and longer follow-up are warranted.

23 April 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
AOAlexander Oscar
Alexander Oscar
RDRadomir Dzhambazov
Radomir Dzhambazov
NVNevyana Veleva-Krasteva
Nevyana Veleva-Krasteva
VHVasil Haykin
Vasil Haykin
YZYani Zdravkov
Yani Zdravkov
Retinopathy of prematurity (ROP) is one of the most serious eye diseases affecting prematurely born infants. Modern treatment methods, including laser photocoagulation, have significantly reduced the incidence of blindness and severe visual impairment due to tractional retinal detachment, macular folds, or excessive myopia. However, long-term complications are still observed in some patients, among which cataract formation holds particular significance. The aim of this study was to evaluate the risk of cataract development in premature infants treated for type 1 ROP. We performed a retrospective study during which we studied 660 premature infants (352 boys and 308 girls) for a period of 5 years. Of these, 145 children (21.97%) were diagnosed with ROP at different stages. A total of 97 children (66.9% of those with ROP) underwent treatment for type 1 ROP. Of these, 80 were treated with laser photocoagulation, and 17 with intravitreal anti-VEGF medications. In the remaining 48 children, spontaneous regression of the disease occurred, and no treatment was necessary. During the study period, only one child (1.25%) developed a cataract. The proper balance between laser energy and number of laser spots is crucial for avoiding complications such as cataract formation. Laser therapy for ROP saves the vision of thousands of children worldwide, but it carries a risk of later complications, including cataract formation. Early detection, along with appropriate surgical treatment, optical correction, and occlusion therapy, is crucial for amblyopia prevention and normal visual development. These patients require long-term follow-up and multidisciplinary care to ensure maximum visual potential.

23 October 2026 in Genes
Verified
Journal Article
Open access
PDF file
YKYoanna Ivanova Kaneva
Yoanna Ivanova Kaneva
KKKunka Kamenarova
Kunka Kamenarova
AOAlexander Oscar
Alexander Oscar
GDGabriel Dimitrov
Gabriel Dimitrov
VHVasil Haykin
Vasil Haykin
NVNevyana Veleva-Krasteva
Nevyana Veleva-Krasteva
Background/Objectives: Syndromic retinitis pigmentosa (SRP) presents a significant diagnostic challenge due to marked clinical and genetic heterogeneity. This study aimed to characterize the molecular spectrum of SRP in the previously understudied Bulgarian population, to define its regional allelic architecture and to relate the genetic findings to the main clinical forms of the disease. Methods: A single-centre, retrospective cohort study included 31 patients from 28 unrelated families diagnosed with SRP at the Department of Ophthalmology, University Hospital “Alexandrovska,” Sofia, Bulgaria. The clinical diagnosis was established by ophthalmological and systemic assessment. Molecular diagnosis was established using whole-exome sequencing of nuclear and mitochondrial DNA and/or targeted inherited retinal disease panel sequencing, complemented by copy number variation analysis. Variants were filtered according to rarity and sequencing quality and classified according to ACMG criteria. Results: The underlying etiology was resolved in all 31 patients across ten ciliary and mitochondrial loci (USH2A, USH1C, ADGRV1, CDH23, IFT54, BBS1, BBS4, BBS10, MKKS, and MT-ATP6). Usher syndrome accounted for 77.41% of cases, followed by Bardet–Biedl syndrome (16.13%), Senior-Løken syndrome spectrum (3.23%), and NARP syndrome (3.23%). Six novel variants were identified. A diagnostic latency of approximately 30 years was observed between the clinical diagnosis and the genetic verification, although the first manifestations, mostly extraocular (congenital hearing loss or polydactyly), appeared in childhood. The allelic landscape demonstrated regional enrichment of the Slavic founder USH2A variant p.(Trp3955*) and the p.(Gly3142*) nonsense variant, while the Western European c.2299delG allele was less prominent. Conclusions: This study defines the molecular spectrum of SRP in a Bulgarian cohort and demonstrates a distinct regional allelic architecture. Recognition of early extraocular manifestations and regional variant frequencies may facilitate earlier diagnosis, improve genetic counseling, and support multidisciplinary management and mutation-specific therapeutic approaches.

29 May 2026 in Pharmacia
Verified
Journal Article
Open access
AOAlexander Oscar
Alexander Oscar
YZYani Zdravkov
Yani Zdravkov
OMOgnyan Mladenov
Ognyan Mladenov
VTValentina Tomova
Valentina Tomova
RGRalitza Georgieva
Ralitza Georgieva
VHVasil Haykin
Vasil Haykin
A retrospective analysis of premature infants screened for retinopathy of prematurity (ROP) in Sofia between 2019 and 2023 included 660 infants. ROP was diagnosed in 145 infants (21.97%). Treatment was required in 97 infants (14.7% of all screened). Laser photocoagulation was performed in 80 infants (82.5% of treated cases), whereas intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy with aflibercept was administered in 17 infants (17.5%), mainly in posterior or aggressive disease. Spontaneous regression occurred in 48 infants (33.1%). No cases of endophthalmitis or systemic adverse events were observed after anti-VEGF therapy. Lower gestational age and birth weight were strongly associated with disease occurrence. These findings indicate that ROP remains a significant clinical challenge in premature infants, whereas pharmacological VEGF inhibition represents an important therapeutic option in selected severe cases, complementing conventional laser treatment.

1 January 2021 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
AOAlexander Oscar
Alexander Oscar
VHVasil Haykin
Vasil Haykin
VDVioleta Dimitrova
Violeta Dimitrova
IPIva Petkova
Iva Petkova
YZYani Zdravkov
Yani Zdravkov
AIAntonia Isaeva
Antonia Isaeva
Cataract is a leading cause of reversible blindness. Secondary cataract is the result of migration, proliferation, and epithelial-mesenchymal transformation (EMT) of lens epithelial cells (LECs), induced by transforming growth factor beta (TGF beta). The extracellular signal-regulated kinases 1 and 2 (ERK 1/2) and casein kinase 2 (CK2) are important for fundamental cellular processes. This study aimed to evaluate the role of CK2 in the EMT of LECs. Primary LECs cultures were obtained from age-related and type 2 diabetes-induced cataracts. Diabetic LECs were capable of spontaneous in vitro differentiation. Treatment of LECs with TGF beta 2-stimulated ERK1/2 activity, which correlated with the expressed alpha-smooth muscle actin (alpha-SMA). siRNA-mediated attenuation of the endogenous catalytic subunit (alpha) of CK2-inhibited ERK1/2 activity and decreased alpha-SMA expression. This study shows evidence that the function of ERK1/2 is regulated by the constitutively active heterotetrameric protein kinase CK2 in this cellular phenotype. This study enriches the knowledge on LECs physiology in normal and in pathological conditions.